Cargando…
Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise
The search continues for optimal markers that can be utilized to improve bladder cancer detection and to predict disease recurrence. Although no single marker has yet replaced the need to perform cystoscopy and urine cytology, many tests have been evaluated and are being developed. In the future, th...
Autores principales: | Darwiche, Fadi, Parekh, Dipen J., Gonzalgo, Mark L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626910/ https://www.ncbi.nlm.nih.gov/pubmed/26604437 http://dx.doi.org/10.4103/0970-1591.166448 |
Ejemplares similares
-
Operative technique and early experience for robotic-assisted laparoscopic nephroureterectomy (RALNU) using da Vinci Xi
por: Darwiche, Fadi, et al.
Publicado: (2015) -
Robotic Partial Nephrectomy with the Da Vinci Xi
por: Kallingal, George J. S., et al.
Publicado: (2016) -
The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019) -
Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments
por: Goldberg, Ilana P., et al.
Publicado: (2022) -
The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer
por: Shi, Ying, et al.
Publicado: (2023)